ArticleOncoimmunology2022

MICA/B-targeted antibody promotes NK cell-driven tumor immunity in patients with intrahepatic cholangiocarcinoma.

Barbara Oliviero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.